NCT02155777View on ClinicalTrials.gov

Why do Oral Contraceptives Prevent Ovarian Cancer?

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2018

Study Completion Date

June 30, 2018

Conditions
Ovarian Cancer RiskRisk-reducing SurgeryFallopian Tube FimbriaeOvarian Cortical Inclusion Cysts
Interventions
DRUG

OrthoNovum 1/35

Trial Locations (3)

48109

University of Michigan, Ann Arbor

90089

USC Keck School of Medicine, Los Angeles

V6T 1Z3

UBC BC Cancer Agency, Vancouver

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Michigan

OTHER

NCT02155777 - Why do Oral Contraceptives Prevent Ovarian Cancer? | Biotech Hunter | Biotech Hunter